Chad M. VanDenBerg

Pharmacokinetics and Absolute Bioavailability of Selegiline Following Treatment of Healthy Subjects With the Selegiline Transdermal System (6 mg/24 h): A Comparison With Oral Selegiline Capsules

Albert J. Azzaro, John A. Ziemniak, Eva M. Kemper et al. · The Journal of Clinical Pharmacology · 2007 · 60 citations

Translational Medicine, Oral Selegiline Capsules, Healthy Subjects +8

The use of the hCG stimulation test in the endocrine evaluation of cryptorchidism

Mark Davenport, Caroline Brain, Chad M. VanDenBerg et al. · British Journal of Urology · 1995 · 53 citations

Tyramine Pharmacokinetics and Reduced Bioavailability with Food

Chad M. VanDenBerg, Lawrence F. Blob, Eva M. Kemper et al. · The Journal of Clinical Pharmacology · 2003 · 49 citations

Nutrition, Tyramine Elimination Half-life, Tyramine Challenge Studies +9

Pharmacokinetics of three formulations of ondansetron hydrochloride in healthy volunteers: 24-mg oral tablet, rectal suppository, and i.v. infusion

Chad M. VanDenBerg, Yusuf Kazmi, James T. Stewart et al. · American Journal of Health-System Pharmacy · 2000 · 46 citations

Tyramine Pressor Sensitivity During Treatment With the Selegiline Transdermal System 6 mg/24 h in Healthy Subjects

Albert J. Azzaro, Chad M. VanDenBerg, Lawrence F. Blob et al. · The Journal of Clinical Pharmacology · 2006 · 45 citations